Overview

  • Product nameAnti-CDC42EP3 antibody - N-terminal
    See all CDC42EP3 primary antibodies
  • Description
    Rabbit polyclonal to CDC42EP3 - N-terminal
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide selected from the N terminal region of Human CDC42EP3 conjugated to KLH (NP_006440.2).

  • Positive control
    • 293 cell line lysates.

Properties

Applications

Our Abpromise guarantee covers the use of ab93594 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
ELISA
  • Application notesELISA: 1/1000.
    WB: 1/100 - 1/500. Predicted molecular weight: 28 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • RelevanceCDC42EP3 is probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. It induces pseudopodia formation in fibroblasts.
    • Cellular localizationEndomembrane system; Peripheral membrane protein. Cytoplasm; cytoskeleton.
    • Database links
    • Alternative names
      • Binder of Rho GTPases 2 antibody
      • BORG2 antibody
      • CDC42 effector protein (Rho GTPase binding) 3 antibody
      • Cdc42 effector protein 3 antibody
      • CEP3 antibody
      • CRIB containing BORG2 protein antibody
      • MSE55 related Cdc42 binding protein antibody
      • MSE55 related protein antibody
      • UB1 antibody
      see all

    Anti-CDC42EP3 antibody - N-terminal images

    • Anti-CDC42EP3 antibody - N-terminal (ab93594) at 1/100 dilution + 293 cell line lysates at 35 µg

      Predicted band size : 28 kDa

    References for Anti-CDC42EP3 antibody - N-terminal (ab93594)

    This product has been referenced in:
    • Clark R  et al. Comparative Genomic and Proteomic Analysis of Cytoskeletal Changes inDexamethasone-Treated Trabecular Meshwork Cells. Mol Cell Proteomics : (2012). WB ; Human . Read more (PubMed: 23105009) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab93594.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"